Despite the recent $21 billion loss in DeFi within the past two weeks, the DEX space is still drawing in high trading volumes and investors are pouring in their funds to assure its future.

DEX, DeFi, InvestmentsRead More

You might also be interested in reading Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma.